2021 ´ëÇÑÇ÷¾×ÇÐȸ ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ 2Â÷ ½ÉÆ÷Áö¾ö : 2021-11-19±³À°ÀÏÀÚ : 2021-11-19
±³À°Àå¼Ò : È£ÅÚ¸®º£¶ó û´ã
±³À°ÁÖÁ¦ :
2021 ´ëÇÑÇ÷¾×ÇÐȸ ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ 2Â÷ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 40¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-19 A·ë 14:00~14:40 Review of recent pediatric ALL clinical study results ÀÌÀç¹Î(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11-19 A·ë 14:40~15:20 Brief review about recent advancement of targeted and immunotherapy in pediatric ALL À¯Àç¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-19 A·ë 15:20~15:40 Practical issue of MRD1 ¾È¾Æ¸®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-19 A·ë 15:40~16:00 Practical issue of MRD2 ÀÌÁö¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-19 A·ë 16:40~17:10 Special Issues in Treatment of ALL ±¸È«È¸(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-19 A·ë 17:10~17:40 International Incidence of Childhood Cancer (IICC) vol. IIII by IARC ½ÅÈñ¿µ(´ëÇÑÀû½ÊÀÚ»ç)